Safety data sheets
Mission & Values
> Press Releases
Press Release: Phadia AB expands its offering in the field of antidrug antibody (ADA) testing and personalized medicine - through a collaboration with Biomonitor A/S »
Uppsala, Sweden and Copenhagen, Denmark, August 22, 2011 Phadia AB and Biomonitor A/S announced today a collaboration in the field of immunogenicity testing and monitoring of ...
Phadia announces first-ever commercial availability of peanut allergen component tests
uKnow Peanut Test™, a new, more precise peanut allergy test, provides physicians and patients molecular level clarity to aid in the diagnosis and help assess the risk of allergic ...
Phadia at the largest Clinical Lab Expo in the World
Phadia will be present at the AACC 2011 Conference at the Georgia Congress Center, July 26–28.
Phadia First Company To Receive FDA Clearance Of Recombinant Allergen Component Tests
510(k) clearance covers 13 molecular allergen components. Newly-available tests provide deepest clinical insight into peanut allergy, as well as allergies to cat dander, dust ...
Landmark Study Affirms The Clinical Utility of ImmunoCAP Allergy Testing
"Allergies Across America” Health Trends Report Published by Quest Diagnostics Spotlights the Importance of Allergy Diagnosis and Treatment to halt the allergic march to asthma, ...
New Guidelines Confirm The Significant Role of ImmunoCAP Specific IgE Test In The Diagnosis And Management of Food Allergy
Phadia is on the cutting edge of advancing the understanding of immunology with the development of Innovative allergen component testing
Phadia Receives FDA 510(k) Clearance
New EliA® assays will allow the laboratory unmatched performance and simplicity to provide physicians better tools to diagnose and manage celiac disease.
September Asthma Epidemic Lurks
Asthma deaths and hospitalizations peak 17 days after Labor Day; easy-to-implement preventive measures can save lives, help people with asthma breathe easier
© 2012 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific Inc. and its subsidiaries.
Legal Manufacturer: Phadia AB, Uppsala, Sweden.